Trevena (TRVN) Stock: Falling Hard On FDA News

vnTrevena Inc (NASDAQ: TRVN) is having an overwhelmingly rough start to the trading session in the pre-market hours this morning, and for good reason. The FDA released briefing documents for an upcoming advisory board meeting, leading to concerns about the company’s candidate. Of course, concerned investors generally equate to declines, and that’s exactly what we’re … Read more

Trevena (TRVN) Stock: Massive Declines After Positive Study Release

Trevena Inc (NASDAQ: TRVN) Trevena is having an incredibly rough day in the market today, which is surprising to many considering that the company released data showing that it met its primary endpoint in recent clinical studies. Below, we’ll talk about what we’re seeing from TRVN, why, and what we’ll be watching for ahead. What … Read more